These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 18705285)

  • 1. Identification of genes associated with multiple nodules in hepatocellular carcinoma using cDNA microarray: multicentric occurrence or intrahepatic metastasis?
    Nakata T; Seki N; Miwa S; Kobayashi A; Soeda J; Nimura Y; Kawasaki S; Miyagawa S
    Hepatogastroenterology; 2008; 55(84):865-72. PubMed ID: 18705285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identify metastasis-associated genes in hepatocellular carcinoma through clonality delineation for multinodular tumor.
    Cheung ST; Chen X; Guan XY; Wong SY; Tai LS; Ng IO; So S; Fan ST
    Cancer Res; 2002 Aug; 62(16):4711-21. PubMed ID: 12183430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
    Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
    Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression.
    Mas VR; Maluf DG; Stravitz R; Dumur CI; Clark B; Rodgers C; Ferreira-Gonzalez A; Fisher RA
    Liver Transpl; 2004 May; 10(5):607-20. PubMed ID: 15108252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
    Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
    Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search.
    Moribe T; Iizuka N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Hamamoto Y; Sakamoto K; Tamesa T; Oka M
    Int J Oncol; 2008 Nov; 33(5):949-58. PubMed ID: 18949357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method.
    Iizuka N; Oka M; Yamada-Okabe H; Mori N; Tamesa T; Okada T; Takemoto N; Tangoku A; Hamada K; Nakayama H; Miyamoto T; Uchimura S; Hamamoto Y
    Cancer Res; 2002 Jul; 62(14):3939-44. PubMed ID: 12124323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
    Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
    Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a rainbow trout oligonucleotide microarray to determine transcriptional patterns in aflatoxin B1-induced hepatocellular carcinoma compared to adjacent liver.
    Tilton SC; Gerwick LG; Hendricks JD; Rosato CS; Corley-Smith G; Givan SA; Bailey GS; Bayne CJ; Williams DE
    Toxicol Sci; 2005 Dec; 88(2):319-30. PubMed ID: 16141433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular signature in three types of hepatocellular carcinoma with different viral origin by oligonucleotide microarray.
    Iizuka N; Oka M; Yamada-Okabe H; Hamada K; Nakayama H; Mori N; Tamesa T; Okada T; Takemoto N; Matoba K; Takashima M; Sakamoto K; Tangoku A; Miyamoto T; Uchimura S; Hamamoto Y
    Int J Oncol; 2004 Mar; 24(3):565-74. PubMed ID: 14767541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-2 gene expression is a new biological prognostic marker in hepatocellular carcinomas.
    Ikeguchi M; Hirooka Y
    Onkologie; 2005 May; 28(5):255-9. PubMed ID: 15867481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of platelet-derived growth factor receptor alpha in endothelial cells of hepatocellular carcinoma associated with high metastatic potential.
    Zhang T; Sun HC; Xu Y; Zhang KZ; Wang L; Qin LX; Wu WZ; Liu YK; Ye SL; Tang ZY
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8557-63. PubMed ID: 16361537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic features between multicentric occurence and intrahepatic metastasis of multiple hepatocellular carcinomas related to HBV.
    Wang J; Li Q; Sun Y; Zheng H; Cui Y; Li H; Zhou H; Hao X
    Surg Oncol; 2009 Mar; 18(1):25-30. PubMed ID: 18640032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues.
    Murakami Y; Yasuda T; Saigo K; Urashima T; Toyoda H; Okanoue T; Shimotohno K
    Oncogene; 2006 Apr; 25(17):2537-45. PubMed ID: 16331254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis.
    Ng IO; Guan XY; Poon RT; Fan ST; Lee JM
    J Pathol; 2003 Mar; 199(3):345-53. PubMed ID: 12579536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma.
    Cheung ST; Leung KL; Ip YC; Chen X; Fong DY; Ng IO; Fan ST; So S
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):551-6. PubMed ID: 15701840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
    Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
    Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different molecular pathways determining extrahepatic and intrahepatic recurrences of hepatocellular carcinoma.
    Iizuka N; Tamesa T; Sakamoto K; Miyamoto T; Hamamoto Y; Oka M
    Oncol Rep; 2006 Nov; 16(5):1137-42. PubMed ID: 17016605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGFBP-3 expression in hepatocellular carcinoma involves abnormalities in TGF-beta and/or Rb signaling pathways.
    Yumoto E; Nakatsukasa H; Hanafusa T; Yumoto Y; Nouso K; Matsumoto E; Onishi T; Takuma Y; Tanaka H; Fujikawa T; Suzuki M; Uemura M; Shiratori Y
    Int J Oncol; 2005 Nov; 27(5):1223-30. PubMed ID: 16211216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential gene expression in distinct virologic types of hepatocellular carcinoma: association with liver cirrhosis.
    Iizuka N; Oka M; Yamada-Okabe H; Mori N; Tamesa T; Okada T; Takemoto N; Hashimoto K; Tangoku A; Hamada K; Nakayama H; Miyamoto T; Uchimura S; Hamamoto Y
    Oncogene; 2003 May; 22(19):3007-14. PubMed ID: 12771952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.